LEMAITRE VASCULAR, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
LEMAITRE VASCULAR, INC. (LMAT) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$521.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-04.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-04
- LEMAITRE VASCULAR, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was -$521.00K.
- LEMAITRE VASCULAR, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was -$24.18M.
- LEMAITRE VASCULAR, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$2.34M.
- LEMAITRE VASCULAR, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$753.00K.
- LEMAITRE VASCULAR, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$28.96M.
- LEMAITRE VASCULAR, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$17.21M.
- LEMAITRE VASCULAR, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$3.48M.
- LEMAITRE VASCULAR, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$7.75M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2018-03-31 | -$521.00K 10-Q · filed 2018-05-04 | -$24.70M derived: sum of 2 quarters · filed 2018-05-04 | -$27.04M derived: sum of 3 quarters · filed 2018-05-04 | -$27.79M derived: sum of 4 quarters · filed 2018-05-04 |
| 2017-12-31 | -$24.18M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$26.51M derived: sum of 2 quarters · filed 2018-03-09 | -$27.27M derived: sum of 3 quarters · filed 2018-03-09 | -$28.96M 10-K · filed 2018-03-09 |
| 2017-09-30 | -$2.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | -$3.09M derived: sum of 2 quarters · filed 2017-11-03 | -$4.78M 10-Q · filed 2017-11-03 | -$17.79M derived: sum of 4 quarters · filed 2018-05-04 |
| 2017-06-30 | -$753.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$2.44M 10-Q · filed 2017-08-03 | -$15.46M derived: sum of 3 quarters · filed 2018-05-04 | -$16.02M derived: sum of 4 quarters · filed 2018-05-04 |
| 2017-03-31 | -$1.69M 10-Q · filed 2018-05-04 | -$14.70M derived: sum of 2 quarters · filed 2018-05-04 | -$15.27M derived: sum of 3 quarters · filed 2018-05-04 | -$15.80M derived: sum of 4 quarters · filed 2018-05-04 |
| 2016-12-31 | -$13.01M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$13.58M derived: sum of 2 quarters · filed 2018-03-09 | -$14.11M derived: sum of 3 quarters · filed 2018-03-09 | -$17.21M 10-K · filed 2018-03-09 |
| 2016-09-30 | -$566.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | -$1.10M derived: sum of 2 quarters · filed 2017-11-03 | -$4.20M 10-Q · filed 2017-11-03 | -$5.06M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-06-30 | -$530.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$3.63M 10-Q · filed 2017-08-03 | -$4.50M derived: sum of 3 quarters · filed 2018-03-09 | -$5.07M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-03-31 | -$3.10M 10-Q · filed 2017-05-04 | -$3.97M derived: sum of 2 quarters · filed 2018-03-09 | -$4.54M derived: sum of 3 quarters · filed 2018-03-09 | -$6.12M derived: sum of 4 quarters · filed 2018-03-09 |
| 2015-12-31 | -$865.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$1.43M derived: sum of 2 quarters · filed 2018-03-09 | -$3.02M derived: sum of 3 quarters · filed 2018-03-09 | -$3.48M 10-K · filed 2018-03-09 |
| 2015-09-30 | -$569.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | -$2.15M derived: sum of 2 quarters · filed 2016-11-04 | -$2.62M 10-Q · filed 2016-11-04 | -$4.00M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-06-30 | -$1.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | -$2.05M 10-Q · filed 2016-08-05 | -$3.43M derived: sum of 3 quarters · filed 2017-03-09 | -$9.04M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-03-31 | -$461.00K 10-Q · filed 2016-05-06 | -$1.85M derived: sum of 2 quarters · filed 2017-03-09 | -$7.46M derived: sum of 3 quarters · filed 2017-03-09 | -$7.57M derived: sum of 4 quarters · filed 2017-03-09 |
| 2014-12-31 | -$1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$7.00M derived: sum of 2 quarters · filed 2017-03-09 | -$7.11M derived: sum of 3 quarters · filed 2017-03-09 | -$7.75M 10-K · filed 2017-03-09 |
| 2014-09-30 | -$5.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$5.72M derived: sum of 2 quarters · filed 2015-11-06 | -$6.36M 10-Q · filed 2015-11-06 | -$6.68M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-06-30 | -$110.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$749.00K 10-Q · filed 2015-08-06 | -$1.07M derived: sum of 3 quarters · filed 2016-03-10 | -$4.65M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-03-31 | -$639.00K 10-Q · filed 2015-05-07 | -$957.00K derived: sum of 2 quarters · filed 2016-03-10 | -$4.54M derived: sum of 3 quarters · filed 2016-03-10 | -$6.03M derived: sum of 4 quarters · filed 2016-03-10 |
| 2013-12-31 | -$318.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | -$3.90M derived: sum of 2 quarters · filed 2016-03-10 | -$5.39M derived: sum of 3 quarters · filed 2016-03-10 | -$6.19M 10-K · filed 2016-03-10 |
| 2013-09-30 | -$3.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$5.08M derived: sum of 2 quarters · filed 2014-11-06 | -$5.87M 10-Q · filed 2014-11-06 | |
| 2013-06-30 | -$1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$2.29M 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | -$795.00K 10-Q · filed 2014-05-08 | |||
| 2012-12-31 | -$5.20M 10-K · filed 2015-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |